Molecular Data Inc.
Molecular Data Inc. (MKDTY) Revenue
Annual & quarterly revenue history · segment & region breakdown
MKDTY · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsMolecular Data Inc. trailing twelve-month (TTM) revenue is $11.09B, a decrease of 42.65% year-over-year from $7.60B in FY2020.
Revenue trend
2020 – 2016 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2020-12-31 | $7.60B | -$5.65B | -42.65% |
| 2019-12-31 | $13.25B | +$4.19B | +46.31% |
| 2018-12-31 | $9.05B | +$4.85B | +115.46% |
| 2017-12-31 | $4.20B | +$1.00B | +31.06% |
| 2016-12-31 | $3.21B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Molecular Data Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Molecular Data Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CNY.
Data sourced from Molecular Data Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
MKDTY revenue · 4 questionsMKDTY's trailing twelve-month (TTM) revenue is $11.09B. That is a decrease of 42.65% year-over-year from $7.60B in FY2020.
▸ Source: FMP · Molecular Data Inc. SEC filings · GAAP · Molecular Data Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026